# EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders

> **NCT04123483** · PHASE4 · WITHDRAWN · sponsor: **Massachusetts General Hospital**

## Conditions studied

- Premenstrual Syndrome
- Premenstrual Dysphoric Disorder
- Premenstrual Tension
- Menstrual Related Mood Disorder

## Interventions

- **DRUG:** EnBrace HR Softgel

## Key facts

- **NCT ID:** NCT04123483
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2019-11
- **Primary completion:** 2021-11
- **Final completion:** 2022-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Cancellation of funding contract
- **Last updated:** 2020-01-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04123483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04123483, "EnBrace HR for PMS With Prominent Mood Symptoms or Menstrual Related Mood Disorders". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04123483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*